Emerging research suggest Retatru tide , a dual stimulator targeting both GLP-1 and GIP , could provide a promising step forward for body management . Early clinical investigations have shown considerable losses in visceral tissue, potentially exceeding other body composition therapies . Despite this, further study is needed to fully determine its